Company Search:
Advanced Search
Sponsored Links
Immuno-Biological Laboratories Company Limited Company Snapshot
Immuno-Biological Laboratories Company Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immuno-Biological Laboratories Company Limited with three other drug stores in Asia: Hong Kong Life Sciences and Technologies Group Ltd of Hong Kong (2017 sales of 153.57 million Hong Kong Dollars [US$19.66 million] of which 79% was Trading Business), Muller and Phipps (Ceylon) Plc of Sri Lanka (898.61 million Sri Lanka Rupees [US$5.85 million] ), and Extrawell Pharmaceutical Holdings Limited which is based in Hong Kong (107.90 million Hong Kong Dollars [US$13.82 million] ).

Sales Analysis. During the year ended March of 2017, sales at Immuno-Biological Laboratories Company Limited were ¥741.53 million (US$6.67 million). This is an increase of 3.3% versus 2016, when the company's sales were ¥717.66 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immuno-Biological Laboratories Company Limited
  Stock Performance Chart for Immuno-Biological Laboratories Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 861.00
(Figures in Japanese Yen)
1 Week 2.6%   13 Weeks 4.7%  
4 Weeks 10.0%   52 Weeks -0.6%  
Immuno-Biological Laboratories Company Limited Key Data:
  Ticker: 4570 Country: Japan
  Exchanges: TYO JSQ Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 741,525,000
(Year Ending Jan 2018).
Employees: 54
  Currency: Japanese Yen Market Cap: 6,387,294,060
  Fiscal Yr Ends: March Shares Outstanding: 7,418,460
  Share Type: Common Closely Held Shares: 1,822,800
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.